Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

9.1K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.1K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

9.3K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
9.3K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

3.0K
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026
Same author

Correcting spatial transcriptomics data affected by a prevalent transcript leakage problem across platforms, species, and tissues.

bioRxiv : the preprint server for biology·2026
Same author

Spatial transcriptomics in Alzheimer's disease: technologies, challenges and discoveries.

Molecular neurodegeneration advances·2026
Same author

HIRA-mediated H3.3 deposition preserves hepatocyte cell identity during liver aging.

Research square·2026
Same author

Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancer.

Neoplasia (New York, N.Y.)·2026
Same author

SAKURA: a knowledge-guided approach to recovering important, rare signals from single-cell data.

Genome biology·2026
Same journal

Somatic mobility of transposons is explosive and shaped by distinct integration biases in Arabidopsis thaliana.

Genome biology·2026
Same journal

UK Biobank whole-genome sequencing reveals robust contributions of rare variants to complex-trait heritability.

Genome biology·2026
Same journal

A one-week automated genome-wide optical pooled screen using OttoSeq.

Genome biology·2026
Same journal

Integrated lipidomic and transcriptomic profiling of the host response in human malaria.

Genome biology·2026
Same journal

Centromeric satellite expansion drives genome evolution in the snowy owl.

Genome biology·2026
Same journal

Mapping the landscape of allele-specific expression in porcine genomes.

Genome biology·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer.

Yao Fu1, Zhu Liu, Shaoke Lou

  • 1Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.

Genome Biology
|October 3, 2014
PubMed
Summary
This summary is machine-generated.

Identifying noncoding cancer drivers is challenging. FunSeq2 is a computational framework that annotates and prioritizes these mutations using a weighted scoring system integrating genomic and cancer data.

More Related Videos

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

9.8K
High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq
09:06

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

Published on: October 5, 2018

10.0K

Related Experiment Videos

Last Updated: Apr 23, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

9.8K
High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq
09:06

High-throughput Identification of Gene Regulatory Sequences Using Next-generation Sequencing of Circular Chromosome Conformation Capture 4C-seq

Published on: October 5, 2018

10.0K

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Identifying noncoding driver mutations from thousands of somatic alterations in tumors is a significant challenge in cancer research.
  • Noncoding regions play crucial roles in gene regulation, and mutations within them can drive cancer development.

Purpose of the Study:

  • To present FunSeq2, a computational framework designed to annotate and prioritize noncoding mutations.
  • To provide a tool for researchers to identify potential noncoding driver mutations in cancer.

Main Methods:

  • FunSeq2 integrates large-scale genomics and cancer resources within an adjustable data context.
  • A streamlined variant-prioritization pipeline employs a weighted scoring system.
  • The scoring system considers inter- and intra-species conservation, loss- and gain-of-function transcription-factor binding events, enhancer-gene linkages, network centrality, and recurrence across samples.

Main Results:

  • The framework successfully annotates and prioritizes noncoding mutations.
  • Putative drivers can be highlighted using sample-specific information, such as differential gene expression.

Conclusions:

  • FunSeq2 offers a robust computational approach to tackle the challenge of identifying noncoding drivers in cancer.
  • The framework aids in uncovering novel cancer-driving mutations within noncoding genomic regions.